GGrantIndex
← Search

CLINICAL TRIAL OF OPC 12759 FOR TREATMENT OF NON ULCER DYSPEPSIA

$241M01FY2000RRNIH

University Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

Abstract

Phase II study to evaluate safety and efficacy of OPC-12759 (Rebamipide) in patients with at least a 12 week history of upper abdominal pain or discomfort occurring 3 times a week, for which no lesion or systemic disease is responsible.

View original record on NIH RePORTER →